Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

1.

MicroRNA signature in the chemoprevention of functionally-enriched stem and progenitor pools (FESPP) by Active Hexose Correlated Compound (AHCC).

Graham ÉA, Mallet JF, Jambi M, Nishioka H, Homma K, Matar C.

Cancer Biol Ther. 2017 Oct 3;18(10):765-774. doi: 10.1080/15384047.2017.1373211. Epub 2017 Sep 8.

2.

Glabridin inhibits cancer stem cell-like properties of human breast cancer cells: An epigenetic regulation of miR-148a/SMAd2 signaling.

Jiang F, Li Y, Mu J, Hu C, Zhou M, Wang X, Si L, Ning S, Li Z.

Mol Carcinog. 2016 May;55(5):929-40. doi: 10.1002/mc.22333. Epub 2015 May 15.

PMID:
25980823
3.

Long Non-Coding RNA HOTAIR Regulates the Proliferation, Self-Renewal Capacity, Tumor Formation and Migration of the Cancer Stem-Like Cell (CSC) Subpopulation Enriched from Breast Cancer Cells.

Deng J, Yang M, Jiang R, An N, Wang X, Liu B.

PLoS One. 2017 Jan 25;12(1):e0170860. doi: 10.1371/journal.pone.0170860. eCollection 2017.

4.

Role of a polyphenol-enriched preparation on chemoprevention of mammary carcinoma through cancer stem cells and inflammatory pathways modulation.

Vuong T, Mallet JF, Ouzounova M, Rahbar S, Hernandez-Vargas H, Herceg Z, Matar C.

J Transl Med. 2016 Jan 14;14:13. doi: 10.1186/s12967-016-0770-7.

5.

MiRNA Transcriptome Profiling of Spheroid-Enriched Cells with Cancer Stem Cell Properties in Human Breast MCF-7 Cell Line.

Boo L, Ho WY, Ali NM, Yeap SK, Ky H, Chan KG, Yin WF, Satharasinghe DA, Liew WC, Tan SW, Ong HK, Cheong SK.

Int J Biol Sci. 2016 Feb 12;12(4):427-45. doi: 10.7150/ijbs.12777. eCollection 2016.

6.

Active hexose-correlated compound down-regulates sex-determining region Y-box 2 of pancreatic cancer cells.

Nawata J, Kuramitsu Y, Wang Y, Kitagawa T, Tokuda K, Baron B, Akada J, Suenaga S, Kaino S, Maehara S, Maehara Y, Sakaida I, Nakamura K.

Anticancer Res. 2014 Sep;34(9):4807-11.

PMID:
25202061
7.

Estrogen receptor beta as epigenetic mediator of miR-10b and miR-145 in mammary cancer.

Piperigkou Z, Franchi M, Götte M, Karamanos NK.

Matrix Biol. 2017 Dec;64:94-111. doi: 10.1016/j.matbio.2017.08.002. Epub 2017 Aug 8.

PMID:
28797712
8.

Targeting epigenetic regulation of miR-34a for treatment of pancreatic cancer by inhibition of pancreatic cancer stem cells.

Nalls D, Tang SN, Rodova M, Srivastava RK, Shankar S.

PLoS One. 2011;6(8):e24099. doi: 10.1371/journal.pone.0024099. Epub 2011 Aug 31.

9.

Breast cancer stem-like cells are inhibited by a non-toxic aryl hydrocarbon receptor agonist.

Prud'homme GJ, Glinka Y, Toulina A, Ace O, Subramaniam V, Jothy S.

PLoS One. 2010 Nov 3;5(11):e13831. doi: 10.1371/journal.pone.0013831.

10.

Knockdown of miR-21 in human breast cancer cell lines inhibits proliferation, in vitro migration and in vivo tumor growth.

Yan LX, Wu QN, Zhang Y, Li YY, Liao DZ, Hou JH, Fu J, Zeng MS, Yun JP, Wu QL, Zeng YX, Shao JY.

Breast Cancer Res. 2011 Jan 10;13(1):R2. doi: 10.1186/bcr2803.

11.

Expression and regulatory function of miRNA-182 in triple-negative breast cancer cells through its targeting of profilin 1.

Liu H, Wang Y, Li X, Zhang YJ, Li J, Zheng YQ, Liu M, Song X, Li XR.

Tumour Biol. 2013 Jun;34(3):1713-22. doi: 10.1007/s13277-013-0708-0. Epub 2013 Feb 22.

PMID:
23430586
12.

miR-10b expression in breast cancer stem cells supports self-renewal through negative PTEN regulation and sustained AKT activation.

Bahena-Ocampo I, Espinosa M, Ceballos-Cancino G, Lizarraga F, Campos-Arroyo D, Schwarz A, Maldonado V, Melendez-Zajgla J, Garcia‐Lopez P.

EMBO Rep. 2016 May;17(5):648-58. doi: 10.15252/embr.201540678. Epub 2016 Apr 9. Erratum in: EMBO Rep. 2016 Jul;17 (7):1081.

13.

MicroRNA-224 inhibits proliferation and migration of breast cancer cells by down-regulating Fizzled 5 expression.

Liu F, Liu Y, Shen J, Zhang G, Han J.

Oncotarget. 2016 Aug 2;7(31):49130-49142. doi: 10.18632/oncotarget.9734.

14.

Prolonged mammosphere culture of MCF-7 cells induces an EMT and repression of the estrogen receptor by microRNAs.

Guttilla IK, Phoenix KN, Hong X, Tirnauer JS, Claffey KP, White BA.

Breast Cancer Res Treat. 2012 Feb;132(1):75-85. doi: 10.1007/s10549-011-1534-y. Epub 2011 May 7.

PMID:
21553120
15.

MicroRNA-1 down-regulates proliferation and migration of breast cancer stem cells by inhibiting the Wnt/β-catenin pathway.

Liu T, Hu K, Zhao Z, Chen G, Ou X, Zhang H, Zhang X, Wei X, Wang D, Cui M, Liu C.

Oncotarget. 2015 Dec 8;6(39):41638-49. doi: 10.18632/oncotarget.5873.

16.

Chemosensitization and inhibition of pancreatic cancer stem cell proliferation by overexpression of microRNA-205.

Chaudhary AK, Mondal G, Kumar V, Kattel K, Mahato RI.

Cancer Lett. 2017 Aug 28;402:1-8. doi: 10.1016/j.canlet.2017.05.007. Epub 2017 May 20.

17.

Suppressive role exerted by microRNA-29b-1-5p in triple negative breast cancer through SPIN1 regulation.

Drago-Ferrante R, Pentimalli F, Carlisi D, De Blasio A, Saliba C, Baldacchino S, Degaetano J, Debono J, Caruana-Dingli G, Grech G, Scerri C, Tesoriere G, Giordano A, Vento R, Di Fiore R.

Oncotarget. 2017 Apr 25;8(17):28939-28958. doi: 10.18632/oncotarget.15960.

18.

miR-135a Inhibits Cancer Stem Cell-Driven Medulloblastoma Development by Directly Repressing Arhgef6 Expression.

Hemmesi K, Squadrito ML, Mestdagh P, Conti V, Cominelli M, Piras IS, Sergi LS, Piccinin S, Maestro R, Poliani PL, Speleman F, De Palma M, Galli R.

Stem Cells. 2015 May;33(5):1377-89. doi: 10.1002/stem.1958.

19.

miR-148a inhibits self-renewal of thyroid cancer stem cells via repressing INO80 expression.

Sheng W, Chen Y, Gong Y, Dong T, Zhang B, Gao W.

Oncol Rep. 2016 Dec;36(6):3387-3396. doi: 10.3892/or.2016.5203. Epub 2016 Oct 25.

PMID:
27779717
20.

miRNA-34b as a tumor suppressor in estrogen-dependent growth of breast cancer cells.

Lee YM, Lee JY, Ho CC, Hong QS, Yu SL, Tzeng CR, Yang PC, Chen HW.

Breast Cancer Res. 2011;13(6):R116. doi: 10.1186/bcr3059. Epub 2011 Nov 23.

Supplemental Content

Support Center